
    
      Part 1:

      Approximately 8 subjects will be randomized to receive either a single 0.1 mg/kg subcutaneous
      dose of sotatercept or matching placebo in a 3:1 ratio

      Part 2:

      Approximately 8 subjects will be randomized to each of the 3 sequential dose groups (0.3mg/kg
      or 0.5mg/kg or 0.7 mg/kg) with a 3:1 ratio of sotatercept or placebo (6 subjects in the
      sotatercept arm and 2 in the placebo arm). A total of 24-36 subjects may be randomized in the
      3 dose groups.
    
  